scholarly journals Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

2018 ◽  
Vol 65 (5) ◽  
pp. e26944 ◽  
Author(s):  
Robin E. Norris ◽  
Elizabeth Fox ◽  
Joel M. Reid ◽  
Andrew Ralya ◽  
Xiaowei W. Liu ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Oncology Group ◽  
Phase 1 Trial

scholarly journals Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study

2013 ◽  
Vol 61 (5) ◽  
pp. 833-839 ◽  
Author(s):  
Rochelle Bagatell ◽  
Robin Norris ◽  
Ashish M. Ingle ◽  
Charlotte Ahern ◽  
Stephan Voss ◽  
...  
Keyword(s):  
Young Adults ◽  
Solid Tumors ◽  
Phase 1 ◽  
Adolescents And Young Adults ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Phase 1 Trial

scholarly journals A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)

2017 ◽  
Vol 177 (3) ◽  
pp. 467-474 ◽  
Author(s):  
Susan R. Rheingold ◽  
Sarah K. Tasian ◽  
James A. Whitlock ◽  
David T. Teachey ◽  
Michael J. Borowitz ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
Induction Chemotherapy ◽  
Lymphoblastic Leukaemia ◽  
Phase 1 ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Phase 1 Trial

Phase 1 trial of Anvirzel™ in patients with refractory solid tumors

2006 ◽  
Vol 24 (5) ◽  
pp. 423-427 ◽  
Author(s):  
Tarek Mekhail ◽  
Hanspreet Kaur ◽  
Ram Ganapathi ◽  
G. Thomas Budd ◽  
Paul Elson ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Phase 1 Trial

Abstract A092: Phase 1 trial of RO6874813, a novel bispecific FAP-DR5 antibody, in patients with solid tumors

2018 ◽  
Author(s):  
Johanna Bendell ◽  
Jean-Yves Blay ◽  
Philippe Cassier ◽  
Todd Bauer ◽  
Catherine Terret ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Phase 1 Trial

Abstract CT012: Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792)

2016 ◽  
Author(s):  
Geoffrey Shapiro ◽  
Robert Wesolowski ◽  
Mark Middleton ◽  
Craig Devoe ◽  
Anastasia Constantinidou ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Phase 1 Trial

scholarly journals Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors

Cancer ◽  
2014 ◽  
Vol 120 (14) ◽  
pp. 2164-2173 ◽  
Author(s):  
David S. Hong ◽  
Ignacio Garrido-Laguna ◽  
Suhendan Ekmekcioglu ◽  
Gerald S. Falchook ◽  
Aung Naing ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Solid Tumors ◽  
Phase 1 ◽  
Vascular Endothelial ◽  
Advanced Solid Tumors ◽  
Phase 1 Trial ◽  
Dual Inhibition ◽  
Endothelial Growth Factor

scholarly journals Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

Cancers ◽  
2017 ◽  
Vol 9 (12) ◽  
pp. 73 ◽  
Author(s):  
Sidra Anwar ◽  
Wei Tan ◽  
Chi-Chen Hong ◽  
Sonal Admane ◽  
Askia Dozier ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Adverse Events ◽  
Solid Tumors ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Serious Adverse Events ◽  
Phase 1 Trial
Sign in / Sign up

Export Citation Format

Share Document